Why the FDA requests Lot Number in Testing Reports

R

regfocus

#1
FDA request medical device's lot number in surgical mask performance test lab reports and biocompatibility test reports during our 510k submission.

Anybody know if that's FDA's trap for seizing any Lot number deficiency issue?
 
Elsmar Forum Sponsor
M

MIREGMGR

#2
Naturally you have to record what units were tested in any testing program. How else would the test results be able to be provably associated with your development/production product stream?

What do you mean by "trap"? Do you have information that they are unlikely to find out except by using a "trap"?
 

somashekar

Staff member
Super Moderator
#4
FDA request medical device's lot number in surgical mask performance test lab reports and biocompatibility test reports during our 510k submission.

Anybody know if that's FDA's trap for seizing any Lot number deficiency issue?
Performance test lab reports and biocompatibility test reports, are type test reports that are taken up on production sample to assure that they meet the design specification. A lot number assures that the test samples come from a specific production lot, which has all the relevant DHR information. Unlike routine tests, these are not performed on regular production lots.
Therefore the validity of these reports at any future time can be assessed based on the study and comparison of the ongoing lot number DHR. The reviewer, as well as the company can assess the validity or decide to retest based on significance of the changes made. These changes reflect into the DHR.
 

Michael Malis

Quite Involved in Discussions
#5
... A lot number assures that the test samples come from a specific production lot, which has all the relevant DHR information. Unlike routine tests, these are not performed on regular production lots.
Therefore the validity of these reports at any future time can be assessed based on the study and comparison of the ongoing lot number DHR. The reviewer, as well as the company can assess the validity or decide to retest based on significance of the changes made. These changes reflect into the DHR.
As stated above by 3 individuals, lot numbers are used for product Material Traceability. And based on the product, some of the tests ARE performed on regular lots. It is important to remember, that biocompatibility can be affected by raw material. For example, if we have questionable results on the product (made from Polycarbonate, for example) that was perfectly acceptable before, we can evaluate raw material lot to check for the presence of contamination.
 
R

regfocus

#6
Thank everybody's help. I understand ID/Lot/Batch is necessary in the testing report. My question is if FDA concern the tested samples came from single batch/lot or multiple lots.

I saw a FDA guidance "Guidance For Conducting Stability Testing To Support An Expiration Date Labeling Claim For Medical Gloves Draft"

It said,

3. Preparation and Sampling
3.1 An appropriate number of boxes of finished product (i.e., after final packaging and, if applicable, after
sterilization) should be randomly selected from each sampling lot on the day of manufacture.


Does that mean if only single lot was tested will not be accepted by FDA for 510k submission?




Naturally you have to record what units were tested in any testing program. How else would the test results be able to be provably associated with your development/production product stream?

What do you mean by "trap"? Do you have information that they are unlikely to find out except by using a "trap"?
 
M

MIREGMGR

#7
My understanding of the guidance in question is that FDA wants the testing process to fairly represent the production variability of a day's production.

So, if your testing is representative to that extent, they probably will accept your explanation.

If on the other hand it appears to them that your testing essentially was a "snapshot" of production, and there is no evidence that it was fully representative of production variability, they might not accept it.
 
R

regfocus

#8
My understanding of the guidance in question is that FDA wants the testing process to fairly represent the production variability of a day's production.

So, if your testing is representative to that extent, they probably will accept your explanation.

If on the other hand it appears to them that your testing essentially was a "snapshot" of production, and there is no evidence that it was fully representative of production variability, they might not accept it.
1) Does that mean samples from multiple lots is better than from single lot from the FDA expectation perspective?
2) If FDA prefer samples from multiple lots then is there any guidance about how many lots are appropriate?
3) For example, I have samples from 3 lots (Lot#1, Lot#2, Lot#3), and I have 3 product properties (property#1, property#2,property#3) need to be verified via lab tests. How should I arrange the samples to have better representative of production variability? Which of the below protocol is the best?

Protocol 1:
property#1 (Lot#1, Lot#2, Lot#3)
property#2 (Lot#1, Lot#2, Lot#3)
property#3 (Lot#1, Lot#2, Lot#3)

Protocol 2:
property#1 (Lot#1, Lot#1, Lot#1)
property#2 (Lot#2, Lot#2, Lot#2)
property#3 (Lot#3, Lot#3, Lot#3)

Thanks
 
Thread starter Similar threads Forum Replies Date
Z Iterative development and FDA change requests IEC 62304 - Medical Device Software Life Cycle Processes 12
M Informational US FDA Final Guidance – Acceptance Review for De Novo Classification Requests Medical Device and FDA Regulations and Standards News 1
M Informational The FDA Takes Action to Protect Patients from Risk of Certain Textured Breast Implants; Requests Allergan Voluntarily Recall Certain Breast Implants a Medical Device and FDA Regulations and Standards News 0
M Informational US FDA – Requests for Supervisory Review of Certain Decisions Made by the Center for Devices and Radiological Health – Final Rule Medical Device and FDA Regulations and Standards News 0
M Informational US FDA Guidance update – Requests for Feedback and Meetings for Medical Device Submissions: The Q-Submission Program Medical Device and FDA Regulations and Standards News 0
Ajit Basrur FDA Guidance Document - User Fees for 513(g) Requests US Food and Drug Administration (FDA) 3
J FDA regulation on decorative contact lenses Medical Device and FDA Regulations and Standards News 4
P Anyone have an Idea on UAE Medical device registeration- Class B with FDA only Other Medical Device Regulations World-Wide 0
F FDA classification for a mobile app Medical Information Technology, Medical Software and Health Informatics 2
Ed Panek IFU Contact Requirements - FDA and MDD/MDR US Food and Drug Administration (FDA) 1
O Any info on release date of FDA “Computer Software Assurance for Manufacturing and Quality System Software” document? 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 0
P Writing a presubmission to the FDA prior to the De novo submission US Food and Drug Administration (FDA) 4
K FDA - Can we have more than 1 Initial Importer Medical Device and FDA Regulations and Standards News 4
K Two FDA questions regarding UDI (and potentially 803.52 MDR) Other US Medical Device Regulations 0
R Importers - For the FDA Registration/ Listing, is the CMO the importer? Medical Device and FDA Regulations and Standards News 6
P FDA Approved Product Contact Parts ISO 13485:2016 - Medical Device Quality Management Systems 6
O Clarifying FDA definition of "finished device" and “capable of functioning” 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 2
A FDA guidance on non-sterile Medical Device Packaging Medical Device and FDA Regulations and Standards News 6
JoCam FDA Registration for Sub-contract manufacturers Medical Device and FDA Regulations and Standards News 2
M FDA News FDA Releases Draft Guidance Clarifying Application of ISO 10993-1 Biocompatibility Standard Medical Device and FDA Regulations and Standards News 0
M Is IEC 60601-1-2 required by FDA for all electronic medical devices? IEC 60601 - Medical Electrical Equipment Safety Standards Series 1
E Contract manufacturer FDA requirements foreign company US Food and Drug Administration (FDA) 6
P Choice of FDA reviewer US Food and Drug Administration (FDA) 6
J Is Device Tracking Card an actual requirement under FDA regulation? Other US Medical Device Regulations 0
T Definition Human Use (FDA) Definitions, Acronyms, Abbreviations and Interpretations Listed Alphabetically 7
K FDA 510k electrosurgery 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 0
J Leveraging FDA 510k Clearance for International Registrations Other Medical Device Regulations World-Wide 2
shimonv FDA News FDA guidance on Multiple Function Device Products (8/2020) Other US Medical Device Regulations 1
N FDA UDI - Label vs. Labeling - Does the insert need to include UDI? Other US Medical Device Regulations 1
J FDA notification of address change US Food and Drug Administration (FDA) 2
N Usability testing required for FDA IDE (investigational device exemption)? Human Factors and Ergonomics in Engineering 3
A FDA Class Classification for a cabinet 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 1
L FDA Biocompatibility Requirements - Transitory Contact Other US Medical Device Regulations 1
Edward Reesor FDA DM and /or Class I Life Saving US Food and Drug Administration (FDA) 0
Watchcat FDA will not tolerate fraud…meaning what, exactly? Other US Medical Device Regulations 6
K FDA Premarket Cybersecurity Guidance - 4 questions Other US Medical Device Regulations 5
gunnyshore Form FDA 3500A MedWatch eSubmitter 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 5
Watchcat FDA Webinar Series - N95 Respirators Other US Medical Device Regulations 0
M Off-Label Use - Clarification of FDA Policy US Food and Drug Administration (FDA) 1
J Sub-supplier change from manual to automated process - same specs - Report to FDA? 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 2
C FDA Establishment registration - Buying some medical devices from another manufacturer Medical Device and FDA Regulations and Standards News 5
I How to classify a medical device based on FDA? 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 3
dinaroxentool Question about FDA Classification of a Device 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 3
S The US FDA requirements on Disposal of a medical device US Food and Drug Administration (FDA) 1
S FDA Requirements for Medical Device Label Reconciliation 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 1
S What is considered a "core algorithm"? (From an FDA guidance document) Medical Information Technology, Medical Software and Health Informatics 4
B FDA-Medical Device Reporting (MDR )procedure compliant with 21CFR section 803 US Food and Drug Administration (FDA) 0
Stoic Are any medical device companies using the 2011 FDA process validation guidance instead of GHTF/SG3/N99-10:2004? 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 1
D ISO 13485, FDA 21 CFR 820 and Auditing the Accounting Department ISO 13485:2016 - Medical Device Quality Management Systems 5
S FDA's E submitter - For clinical electronic thermometer Medical Device and FDA Regulations and Standards News 6

Similar threads

Top Bottom